|
| ID |
DDInter497 |
| Drug Type |
small molecule |
| Molecular Formula |
C32H52N4O4 |
| Molecular Weight |
556.792
|
| Description |
Demecarium is an indirect-acting parasympathomimetic agent that is used to treat glaucoma. It is a cholinesterase inhibitor or an anticholinesterase. Cholinesterase inhibitors prolong the effect of acetylcholine, which is released at the neuroeffector junction of parasympathetic postganglion nerves, by inactivating the cholinesterases that break it down. Demecarium inactivates both pseudocholinesterase and acetylcholinesterase. In the eye, this causes constriction of the iris sphincter muscle (causing miosis) and the ciliary muscle. The outflow of the aqueous humor is facilitated, which leads to a reduction in intraocular pressure.
|
| ATC Classification |
S01EB04
|
| IUPAC Name |
N,N,N-Trimethyl-3-{[Methyl({10-[Methyl({[3-(Trimethylazaniumyl)Phenoxy]Carbonyl})Amino]Decyl})Carbamoyl]Oxy}Anilinium |
| InChI |
Inchi=1S/C32H52N4O4/C1-33(31(37)39-29-21-17-19-27(25-29)35(3,4)5)23-15-13-11-9-10-12-14-16-24-34(2)32(38)40-30-22-18-20-28(26-30)36(6,7)8/H17-22,25-26H,9-16,23-24H2,1-8H3/Q+2 |
| InChI Key |
RWZVPVOZTJJMNU-UHFFFAOYSA-N |
| Canonical SMILES |
CN(CCCCCCCCCCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C |
| Useful Links |
DrugBank
ChEMBL
PubChem
|